Meb Pharma Private Limited - pharma in Murtizapur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2020PTC335518 Incorporated 06 January 2020 ROC Nagpur HQ Murtizapur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹7.52 Cr
▲ 4% YoY
Net profit · FY 2025
₹65.55 Lakh
Net margin 8.7%
EBITDA · FY 2025
₹1.57 Cr
EBITDA margin 20.9%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹90.5 Lakh
Issued & subscribed
Open charges
₹6.08 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
64
Provident fund records

About Meb Pharma Private Limited

Data last updated:

Meb Pharma Private Limited is a private limited company based in Murtizapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24304MH2020PTC335518. Its GSTIN is 27AANCM2157Q1ZQ (Maharashtra).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹90.5 Lakh. It is led by directors Eknath Pandurang Bhad and Mangesh Eknath Bhad.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O N M Pharma G.No./ S No.33 Kurum Center At Navsal, Murtizapur, Maharashtra, India – 444107.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.52 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹65.55 Lakh (net margin 8.7%) and EBITDA of ₹1.57 Cr (EBITDA margin 20.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 91% over five years.

The company has about 64 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹6.08 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mebpharma.com.

Company Details of Meb Pharma Private Limited
CIN U24304MH2020PTC335518
Registration Number 335518
Incorporation Date 06 January 2020
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    C/O N M Pharma G.No./ S No.33 Kurum Center At Navsal, Murtizapur, Maharashtra, India – 444107
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Meb Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Meb Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Meb Pharma Private Limited in one report.

Financials from FY 2020 Directors & ownership Charges & compliance

Business Activity of Meb Pharma Private Limited

The main business activity of Meb Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Meb Pharma Private Limited FY 2025 filings available

Meb Pharma Private Limited reported revenue of ₹7.52 Cr (up 4% YoY) for FY 2025.

Revenue · FY 2025
₹7.52 Cr ▲ 4%
Net profit · FY 2025
₹65.55 Lakh margin 8.7%
EBITDA · FY 2025
₹1.57 Cr margin 20.9%

Compounded Annual Growth Rate (CAGR) of Meb Pharma Private Limited

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 9%
5 years · compounded
▲ 91%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 33%
5 years · compounded
▲ 53%

Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 4% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Meb Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.57 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹65.55 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Meb Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20.9%••••••••••••••••
Net Profit Margin8.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Meb Pharma are in the company report.

Premium access

Financial statements from FY 2020

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Meb Pharma Private Limited

Meb Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Saprad Colourant Private Limited₹7.54 Cr (FY 2025)••••••••33.0%••••Ahmedabad, Gujarat, India
Suraj Laboratories Private Limited₹7.54 Cr (FY 2025)••••••••1830.0%••••Hyderabad, Telangana, India
P. S. Mint & Allied Products Private Limited₹7.53 Cr (FY 2024)••••••••2.0%••••Chandausi, Uttar Pradesh, India
Viva Cosmetics Private Limited₹7.53 Cr (FY 2025)••••••••-17.0%••••India, Maharashtra
Neerava Hygiene Products India Private Limited₹7.53 Cr (FY 2025)••••••••20.0%••••Howrah, West Bengal, India
Meb Pharma Private Limited this company₹7.52 Cr (FY 2025)••••••••4.0%••••Murtizapur, Maharashtra, India
Elim Chem Private Limited₹7.51 Cr (FY 2024)••••••••-42.0%••••Hyderabad, Telangana, India
Jaysons Ammonia and Chemicals Private Limited₹7.51 Cr (FY 2025)••••••••-49.0%••••Mumbai, Maharashtra, India
Taesung Autoind Private Limited₹7.51 Cr (FY 2025)••••••••-12.0%••••Chennai, Tamil Nadu, India
Rainbow Products Private Limited₹7.5 Cr (FY 2024)••••••••108.0%••••Patna, Bihar, India
Isk Biosciences India Private Limited₹7.5 Cr (FY 2024)••••••••28.0%••••New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Meb Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Meb Pharma Private Limited

Meb Pharma Private Limited is audited by RAMESH CHAUDHARI & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
RAMESH CHAUDHARI & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Meb Pharma Private Limited

Meb Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Eknath Pandurang BhadDirector06 Jan 20206 Years 9 MonthsCurrent
Mangesh Eknath BhadDirector06 Jan 20206 Years 9 MonthsCurrent

Ownership and Shareholding of Meb Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Meb Pharma Private Limited

Open charges
₹6.08 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.22 Cr
Sidbi₹0.81 Cr
Hdfc Bank Limited₹0.05 Cr
Latest charge details
DateLenderAmountStatus
17 Dec 2025Others₹3.15 CrOpen
26 Sep 2025Sidbi₹80.56 LakhOpen
07 Nov 2024Hdfc Bank Limited₹5 LakhOpen
26 Jul 2024Others₹82 LakhOpen
31 Jul 2023Others₹1.25 CrOpen

Total charge records: 5 View all charges

Employees and EPFO Compliance at Meb Pharma Private Limited

Meb Pharma Private Limited has a workforce of 64 employees as of Apr 01, 2024.

Employee count
64
Active EPFO establishments
1
Employee growth
18.52%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Meb Pharma Private Limited

Meb Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Eknath Pandurang Bhad was appointed as Director on 06 Jan 2020.

Charges
A charge with Others amounted to Rs. 3.15 Cr with Charge ID 101227993 was registered on 17 Dec 2025.
AGM
Meb Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 0.81 Cr with Charge ID 101170442 was registered on 26 Sep 2025.
Filing
Meb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.05 Cr with Charge ID 101041008 was registered on 07 Nov 2024.
Charges
A charge with Others amounted to Rs. 0.82 Cr with Charge ID 100965784 was registered on 26 Jul 2024.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100773353 was registered on 31 Jul 2023.
Appointed
Eknath Pandurang Bhad was appointed as Director.
Appointed
Mangesh Eknath Bhad was appointed as Director.
Incorporation
06 Jan 2020
Meb Pharma Private Limited was registered on 06 Jan 2020 with Roc Nagpur & aged 6 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Meb Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Meb Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Meb Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Meb Pharma Private Limited

Meb Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AANCM2157Q1ZQMaharashtraActive06 Jan 2020
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Meb Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meb Pharma Private Limited

Meb Pharma is an active private limited company based in Murtizapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 2020 (6+ years old) and is registered under CIN U24304MH2020PTC335518.

Meb Pharma reported revenue of ₹7.52 Cr for FY 2025 (up 4% YoY).

Meb Pharma has 2 current directors:

Meb Pharma reported a net profit of ₹65.55 Lakh (net margin 8.7%) and EBITDA of ₹1.57 Cr (EBITDA margin 20.9%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Meb Pharma is 9% over three years and 91% over five years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Meb Pharma is 27AANCM2157Q1ZQ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Meb Pharma is U24304MH2020PTC335518. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Meb Pharma has 4 court cases on record: 4 filed by the company. 2 are pending.

Meb Pharma was incorporated on 06 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Nagpur.

The peers of Meb Pharma by revenue are Saprad Colourant Private Limited, Suraj Laboratories Private Limited, P. S. Mint & Allied Products Private Limited, Viva Cosmetics Private Limited, Neerava Hygiene Products India Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Eknath Pandurang Bhad was appointed as Director on 06 Jan 2020. Mangesh Eknath Bhad was appointed as Director on 06 Jan 2020.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available